← Back

Sugentech Inc

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. Its offerings include lab tests with associated systems and test items, COVID-19 tests, and point-of-care testing analyzers and test items for influenza A/B, antibody testing, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP. It also provides digital health and home tests such as mobile health, ovulation, and pregnancy products. The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013; it was founded in 2011 and is headquartered in Daejeon, South Korea.

Price · split & dividend adjusted
News & notes moving 253840.KQ